Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014
Open Access
- 1 October 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 175 (10) , 1681-1687
Abstract
Insulin was isolated in the late 1800s and first injected into a patient with diabetes mellitus in 1922.1,2 Banting, Best, and Collip licensed their patent for the process of isolating insulin for 1 dollar each as a gift to humanity rather than an opportunity for commercial profit.3 The earliest commercial insulin preparations lacked purity and varied in potency.4 Manufacturing improvements over the past 90 years have resulted in safer and more convenient forms of insulin for patients with diabetes mellitus.3,5Keywords
This publication has 19 references indexed in Scilit:
- Why Is There No Generic Insulin? Historical Origins of a Modern ProblemNew England Journal of Medicine, 2015
- Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010JAMA, 2014
- Insulin therapy: a pocket guideEuropean Diabetes Nursing, 2013
- Newer insulins in type 2 diabetesBMJ, 2012
- Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*Diabetic Medicine, 2010
- Nice insulins, pity about the evidenceDiabetologia, 2007
- Health care resource utilization and expenditures associated with the use of insulin glargineClinical Therapeutics, 2007
- Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database AnalysisClinical Therapeutics, 2007
- Cost and Utilization Comparisons Among Propensity Score-Matched Insulin Lispro and Regular Insulin UsersJournal of Managed Care Pharmacy, 2003
- Milestones in the 60-Year History of Insulin: (1922–1982)Diabetes Care, 1982